Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 3Prostatic Neoplasms 2Fatigue 2Breast Neoplasms 2Xerostomia 1Vomiting 1Uterine Cervical Neoplasms 1Psychological Well-Being 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Obesity 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Mucositis 1Motor Activity 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Hyperinsulinism 1Head and Neck Neoplasms 1Esophagitis 1Digestive System Diseases 1Colon or Upper Rectum Adenocarcinoma 1Brain Neoplasms 1

Interventions

Metformin 4Exenatide 2semaglutide 1lime 1dapagliflozin 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Sugars 1Sugammadex 1Sodium-Glucose Transporter 2 Inhibitors 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Qsymia 1Paclitaxel 1Liraglutide 1Letrozole 1Immunoenzyme Techniques 1Glucagon-Like Peptide 1 1Early Intervention, Educational 1Diazoxide 1Counseling 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Obesity × Surveys and Questionnaires × Clear all
NCT01697566 2025-06-11

An Endometrial Cancer Chemoprevention Study of Metformin

M.D. Anderson Cancer Center

Phase 3 Completed
29 enrolled 12 charts
Other

Hyperinsulinism, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡